RESISTANCE TO TARGETED THERAPIES IN MELANOMA: NEW INSIGHTS
Several molecular mechanisms are involved in melanoma genesis and progression. Molecular targets for effective therapeutic intervention have been identified within the RAS-RAF-MEK-ERK and, to a less extent, PI3K-AKT pathways. The development of inhibitors of key effectors (mainly BRAF mutant, MEK, a...
Saved in:
Main Authors: | Giuseppe Palmieri (Author), Maria Colombino (Author), Maria Cristina Sini (Author), Antonella Manca (Author), Paolo Antonio Ascierto (Author), Antonio Cossu (Author) |
---|---|
Format: | Book |
Published: |
European Medical Journal,
2013-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
by: Germana Sini, et al.
Published: (2013) -
Immunotherapy in non-melanoma skin cancer: updates and new perspectives
by: Paolo Antonio Ascierto, et al.
Published: (2019) -
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
by: Irene Vanni, et al.
Published: (2020) -
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
by: Marie Angèle Cucci, et al.
Published: (2023) -
New Insights into Melanoma Tumor Syndromes
by: Sarem Rashid, et al.
Published: (2022)